Investigation of the therapeutic potential of fibroblast activation protein inhibition in type 2 diabetes
Ended Project Grant Awarded Last action
- Award ID
- F32DK107050
- Recipient
-
Sinai Health System UEI EGLGXJ3LM4C9
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $125,870
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Funding
-
- $127,596.34 Federal
- -$1,726.83 Non-federal
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$1,727 | $0 | |
| Amendment | -$1,727 | -$1,727 | |
| Amendment | $9,850 | $0 | |
| Amendment | $53,184 | $0 | |
| Amendment | $8,850 | $0 | |
| Amendment | $50,316 | $0 | |
| Original award | $8,850 | $0 |
Quick answers
Who received award F32DK107050?
F32DK107050 was awarded to Sinai Health System by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 22, 2016.
How much is award F32DK107050 worth?
$125,870 has been obligated on F32DK107050: $127,596 in federal funding and -$1,727 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award